Galmed Pharmaceuticals
GLMD
#11044
Rank
โ‚น0.46 B
Marketcap
โ‚น432.72
Share price
21.05%
Change (1 day)
347.89%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2026 (TTM): -โ‚น1,157

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น1,204. In 2017 the company made an earnings per share (EPS) of -โ‚น1,31,891 an increase over its 2016 EPS that were of -โ‚น2,00,528.

EPS history for Galmed Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น1,157
2017-โ‚น1,31,891-34.23%
2016-โ‚น2,00,52856.84%
2015-โ‚น1,27,853

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Evoke Pharma
EVOK
-โ‚น235.52-80.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-โ‚น100.00-91.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น70.09-94.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-โ‚น591.60-50.85%๐Ÿ‡บ๐Ÿ‡ธ USA